DS
MGNX icon

David Shaw’s MacroGenics MGNX Stock Holding History

David Shaw’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.91M Buy
1,062,991
+4,567
+0.4% +$17.3K ﹤0.01% 2425
2026
Q1 		$3.06M Buy
1,058,424
+301,777
+40% +$644K ﹤0.01% 2575
2025
Q4 		$1.22M Buy
756,647
+534,447
+241% +$840K ﹤0.01% 3409
2025
Q3 		$373K Buy
222,200
+121,689
+121% +$197K ﹤0.01% 4005
2025
Q2 		$122K Buy
100,511
+71,811
+250% +$104K ﹤0.01% 4111
2025
Q1 		$36.4K Buy
+28,700
New +$75K ﹤0.01% 4078
2024
Q4 		– Sell
-119,029
Closed -$392K – 4684
2024
Q3 		$392K Buy
119,029
+4,969
+4% +$19.4K ﹤0.01% 3838
2024
Q2 		$485K Buy
+114,060
New +$1.11M ﹤0.01% 3639
2023
Q3 		– Sell
-90,723
Closed -$485K – 4392
2023
Q2 		$485K Sell
90,723
-60,832
-40% -$375K ﹤0.01% 3434
2023
Q1 		$1.09M Sell
151,555
-342,372
-69% -$2.06M ﹤0.01% 3099
2022
Q4 		$3.31M Sell
493,927
-86,626
-15% -$475K ﹤0.01% 2490
2022
Q3 		$2.01M Sell
580,553
-265,100
-31% -$1.01M ﹤0.01% 3007
2022
Q2 		$2.5M Buy
845,653
+605,055
+251% +$3.18M ﹤0.01% 2875
2022
Q1 		$2.12M Buy
240,598
+181,203
+305% +$2M ﹤0.01% 3239
2021
Q4 		$953K Sell
59,395
-19,317
-25% -$364K ﹤0.01% 3969
2021
Q3 		$1.65M Sell
78,712
-48,932
-38% -$1.18M ﹤0.01% 3197
2021
Q2 		$3.43M Sell
127,644
-234,773
-65% -$6.88M ﹤0.01% 2377
2021
Q1 		$11.5M Sell
362,417
-204,987
-36% -$4.98M 0.01% 1262
2020
Q4 		$13M Sell
567,404
-162,060
-22% -$3.73M 0.01% 1220
2020
Q3 		$18.4M Sell
729,464
-125,188
-15% -$3.42M 0.02% 878
2020
Q2 		$23.9M Buy
854,652
+444,300
+108% +$7.72M 0.03% 691
2020
Q1 		$2.39M Sell
410,352
-198,800
-33% -$1.81M ﹤0.01% 2018
2019
Q4 		$6.63M Buy
609,152
+359,360
+144% +$3.56M 0.01% 1510
2019
Q3 		$3.19M Sell
249,792
-48,646
-16% -$701K ﹤0.01% 2017
2019
Q2 		$5.06M Sell
298,438
-374,805
-56% -$6.44M 0.01% 1583
2019
Q1 		$12.1M Buy
673,243
+652,694
+3,176% +$11.3M 0.02% 989
2018
Q4 		$261K Buy
20,549
+5,921
+40% +$99.3K ﹤0.01% 3428
2018
Q3 		$314K Sell
14,628
-50,842
-78% -$1.08M ﹤0.01% 3338
2018
Q2 		$1.35M Buy
65,470
+45,816
+233% +$1.03M ﹤0.01% 2501
2018
Q1 		$494K Buy
+19,654
New +$477K ﹤0.01% 2895
2015
Q2 		– Sell
-8,843
Closed -$277K – 3816
2015
Q1 		$277K Sell
8,843
-20,136
-69% -$682K ﹤0.01% 3337
2014
Q4 		$1.02M Buy
+28,979
New +$722K ﹤0.01% 2820
2014
Q3 		– Sell
-24,124
Closed -$524K – 4276
2014
Q2 		$524K Buy
+24,124
New +$507K ﹤0.01% 3491

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

David Shaw's MGNX Position: Q2 2026 in Review

David Shaw increased its MacroGenics (MGNX) stake by 0.43% in Q2 2026, buying an estimated $17.3K and bringing the position to 1,062,991 shares worth $4.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2425.

David Shaw first reported a position in MGNX in Q2 2014 and has held it in 33 quarters since. The position peaked at $23.9M in Q2 2020. 121 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • David Shaw held 1,062,991 shares of MacroGenics worth $4.91M as of Q2 2026.
  • David Shaw bought 4,567 MacroGenics shares in Q2 2026, an estimated $17.3K.
  • MacroGenics made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2425 holding.
  • David Shaw first reported a position in MacroGenics in Q2 2014 and has held it in 33 quarters since.
  • David Shaw's MacroGenics position peaked at $23.9M in Q2 2020.
  • 121 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.